Vaccinex, Inc. Common Stock
VCNX
VCNX was delisted on the 17th of December, 2024.
18 hedge funds and large institutions have $2.92M invested in Vaccinex, Inc. Common Stock in 2023 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 4 increasing their positions, 5 reducing their positions, and 9 closing their positions.
193% more capital invested
Capital invested by funds: $995K → $2.92M (+$1.92M)
18% less funds holding
Funds holding: 22 → 18 (-4)
20% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 5
44% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 9
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
AIGH Capital Management
Baltimore,
Maryland
|
+$3.63M |
| 2 |
WVP
Worth Venture Partners
Fort Lee,
New Jersey
|
+$2.57M |
| 3 |
AC
Armistice Capital
New York
|
+$2.47M |
| 4 |
Millennium Management
New York
|
+$49.9K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$45.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$36.7K |
| 2 |
State Street
Boston,
Massachusetts
|
-$25.4K |
| 3 |
Renaissance Technologies
New York
|
-$16K |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$8.32K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$5.69K |
VCNX Hedge Fund Activity: Q3 2023 in Review
18 of the 6,310 institutional investors tracked by Wall St. Rank reported a position in Vaccinex, Inc. Common Stock (VCNX) for Q3 2023, worth a combined $2.92M — up 193% from $995K a quarter earlier.
Sellers outnumbered buyers: 9 funds closed out of VCNX and 5 opened new positions — a net loss of 4 holders — while 5 trimmed existing stakes and 4 added.
The largest buyer was AIGH Capital Management, adding an estimated $3.63M. The largest seller was Citadel Advisors, exiting entirely with an estimated $36.7K sold.
- 18 institutional investors held Vaccinex, Inc. Common Stock (VCNX) as of Q3 2023, down from 22 in Q2 2023.
- Funds reported $2.92M of Vaccinex, Inc. Common Stock stock for Q3 2023, up 193% quarter-over-quarter.
- 5 funds opened new Vaccinex, Inc. Common Stock positions in Q3 2023 and 9 closed out, a net change of -4 holders.
- The largest Vaccinex, Inc. Common Stock buyer in Q3 2023 was AIGH Capital Management, an estimated $3.63M added.
- The largest Vaccinex, Inc. Common Stock seller in Q3 2023 was Citadel Advisors, an estimated $36.7K sold.
Based on aggregated 13F filings for Q3 2023.